Successful management of chronic cough has varied in the primary research studies in the reported literature. One of the potential reasons relates to a lack of intervention fi delity to the core elements of the diagnostic and/or therapeutic interventions that were meant to be used by the investigators.
Summary of Recommendations and Suggestions
1. In conducting studies of chronic cough in adults, we recommend that investigators, as a fi rst step, include intervention fi delity in the design of their studies of the diagnosis and treatment of chronic cough, by addressing intervention fi delity in the following 5 areas: study design, training of providers, treatment delivery, treatment receipt, and enactment of treatment (Grade 1C) .
2.
In conducting studies of chronic cough in adults, we recommend, as a second step, that the training of investigators be addressed; and, all investigators should agree to employ the use of an evidence-based clinical practice guideline or an evidence-based protocol for the diagnosis and treatment of chronic cough and agree to follow an intervention manual outlining the minimum expected interventions throughout the study (Grade 1C) .
In conducting studies of chronic cough in adults,
we recommend that investigators, as a third step, establish a standardized plan for delivery and measurement of treatment through the use of an intervention manual (Grade 1C) . 4 . In conducting studies of chronic cough in adults, we recommend that investigators, as a fourth step, establish a standardized plan for maximizing and measuring concordance of understanding of interventions and treatment between subjects and investigators (Grade 1C) .
5.
In conducting studies of chronic cough in adults, as a fi ft h step, we recommend that investigators establish a standardized plan for evaluating and measuring the subject's ability to enact and adhere to the treatment plan under real life circumstances (Grade 1C) . 6 . In conducting studies of chronic cough in adults, we recommend that investigators not make a diagnosis of idiopathic chronic cough as a distinct clinical entity unless known causes of cough have been excluded by a systematic evaluation using an evidence-based guideline and intervention fi delity has been addressed in the design and implementation of the study (Grade 1C) .
7. In all patients with chronic cough, we suggest that clinicians use an evidence-based guideline that contains core elements and processes as a guide for diagnosis and treatment (Ungraded Consensus-Based Statement) .
Multiple professional societies worldwide have engaged experts to develop evidence-based guidelines to assist providers in the management of chronic cough. 1 Yet, according to the published literature, successful management of chronic cough has varied from 54% to 100%. 2 -4 Although it is not clear what accounts for this variability, one of the potential reasons 5 relates to a lack of intervention fi delity to the core elements of the diagnostic and/or therapeutic interventions that were meant to be used by the investigators.
Although descriptors and defi nitions for intervention fi delity vary in content and detail, they are conceptually similar. Intervention fi delity has been defi ned as "the extent to which an intervention was delivered as conceived and planned-to arrive at valid conclusions concerning its eff ectiveness in achieving the target outcomes. " 6 Th e concept of intervention fi delity is an important methodologic consideration when conducting primary research in randomized controlled clinical trials as well as nonrandomized observational studies, to ensure reliable and valid testing of an intervention. 7 -11 When using the randomized controlled study design, the importance of establishing a plan for standardized, consistent implementation of the intervention by both the investigator and the subject is well recognized. Randomized study designs routinely include measures for issues such as patient adherence to therapy to ensure fi delity to the intervention that is being tested. However, despite strong study designs, when interventions are fl exible, dynamic, and individualized, even randomized controlled trials can be subject to problems related to intervention fidelity. 12 In contrast, in the case of nonrandomized, noncontrolled, observational studies assessing the outcomes associated with the implementation of interventions in ambulatory settings, the literature addressing intervention fi delity is not as well established or, in the case of chronic cough, not addressed at all. Because observational studies may provide the best evidence for the real-world implementation of clinical practice guidelines, we decided to evaluate intervention fi delity, according to the Treatment Fidelity Workgroup of the National Institutes of Health (NIH) Behavioral Change Consortium 7 recommendations, in the management of chronic cough as an important unmet need.
Th is systematic review addresses the use of guidelines or protocols for the diagnosis and management of chronic cough, beginning with the publication of the fi rst formal professional society guideline published for this purpose. Th e fi rst formal professional society guideline for the diagnosis and management of chronic cough was published in 1998, and this publication used a defi nition of Ն 3 weeks' duration to defi ne chronic cough. 13 Since at least the year 2000, chronic cough has been defi ned as being of . 8 weeks' duration. 14 Th e 2004 European Respiratory Society, 15 the 2006 American College of Chest Physicians (CHEST), 16 and most guidelines for the diagnosis and management of chronic cough that followed defi ne chronic cough as being of . 8 weeks' duration. For at least these reasons, the literature we reviewed varied in its defi nition of chronic cough.
Th e Treatment Fidelity Workgroup of the NIH Behavioral Change Consortium 7 , 10 , 11 has recommended that the following fi ve areas be addressed to assess intervention fi delity: study design, training of providers, delivery of treatment, receipt of treatment, and enactment of treatment. 7 , 10 , 11 Study design, training of providers, and delivery of treatment focus on the interventionist, whereas receipt and enactment of treatment focus on the patient receiving the intervention. 7 Although these particular strategies were developed for use with behavioral interventions, we adapted them to address intervention fi delity in studies of the use of guidelines or protocols to manage chronic cough. Th e strategies proposed have been incorporated into a visual model ( Fig 1 ) of the logic for the role of intervention fi delity in studies of the diagnosis and management of chronic cough in adults. Th e model demonstrates the importance of the fi ve areas of intervention fi delity specifi c to successful cough guideline implementation. For the impact of these recommendations to be realized as intended, several outcomes need to be achieved. Th e short-term outcome is for the providers to receive and enact the guidelines according to the recommendations. Th e intermediate outcome is that patients will receive and enact the provider recommendations that are based upon the guidelines. Th e long-term outcome is for providers to be competent in guideline delivery by providing accurate diagnoses, with the result being that the patient achieves a reduction in cough severity so that the impact of improved quality of life and reduced burden on the system and society can be achieved. We used this logic model ( Fig 1 ) to guide our assessment of how well authors implemented the use of guidelines or protocols in the studies in our systematic review.
For further clarifi cation of the fi ve areas of intervention fi delity, 7 , 10 the area of study design focuses on establishing clarity of the theoretical underpinnings of the study. Using the management of cough as an example, for this review, the theoretical underpinnings referred to the published evidence-based guidelines or protocols referenced by the author as providing the theoretical rationale for the interventions used in the study. Identifi cation of the supporting published evidencebased guideline or protocol allows one to assess the extent of its relationship to the interventions and therefore the degree to which the guideline has been implemented. Th e area of training of providers refers to educating providers to help them in the maintenance of standardized delivery of the intervention by the interventionist throughout the study. Th is could be accomplished through the use of an intervention manual. Delivery of treatment would relate to the treatment interventions outlined by the identifi ed guideline being used by the provider. Receipt of treatment would refer to verifying that the patient and the interventionist have concordance of understanding of the treatment recommended, whereas enactment of treatment would be exemplifi ed by whether the patient has been able to engage in the use of the recommended treatment in daily life. Enactment of treatment in daily life is a concept that is more broad than that of adherence. 7 For example, a patient may try out new recipes to develop the ability to adhere to an antirefl ux diet; although this may be important to an individual's adherence to the diet recommendation, it is not an equivalent. 7 Receipt and enactment of treatment pertain to the patient rather than the interventionist. 7 , 10 Th e purpose of this study was to systematically evaluate the literature for the use of previously published clinical practice guidelines or protocols for the diagnosis and management of chronic cough in adults. Th is systematic review included: assessing these studies for elements of intervention fidelity, summarizing findings, and establishing recommendations and/or suggestions for future investigators performing clinical research on chronic cough in adults. We hypothesized that routinely incorporating intervention fi delity as a methodologic strategy should improve the reliability and validity of the outcomes of studies using guidelines or protocols in the treatment of chronic cough.
To fulfi ll our purposes and to test this hypothesis, we set out to accomplish four specifi c aims:
1. Develop and pilot a tool that assesses fi ve areas of intervention fi delity in the identifi ed studies. 2. Systematically review the literature on studies that diagnosed and treated an initially unexplained chronic cough in adults using a guideline or protocol and determine whether the fi ve areas of intervention fi delity were addressed in the identifi ed studies and to what degree. 3. Assess whether intervention fi delity was used to the extent that readers can be confi dent that the diagnoses made were valid. 4. Use these fi ndings to provide recommendations and/or suggestions for those conducting research of any design in the area of chronic cough.
Materials and Methods

Systematic Review
Th e Executive Committee of the CHEST Expert Cough Panel convened a writing committee to develop recommendations or suggestions that pertain to the assessment of intervention fi delity in studies of the use of guidelines or protocols to diagnose and manage chronic cough in adults. This writing committee based its recommendations or suggestions on a systematic review contained within this article. This systematic review follows the "Methodologies for the Development of the Management of Cough: CHEST Guideline and Expert Panel Report. " 17 , 18 Eligibility Criteria: The key clinical question, associ ated PICOTS elements (ie, population, intervention, comparator, outcome, timing, setting), and study selec tion criteria were developed ( Table 1 ) , and a systematic review of the literature was performed with the intent of identifying studies that met the following criteria: (1) addressed chronic cough in adults; (2) used evidence-based clinical practice guidelines or protocols to diagnose and manage chronic cough; (3) diagnosed explained and unexplained chronic cough; (4) included any study design with the exception of case reports and letters to the editor because of lack of necessary methodologic details for assessing intervention fi delity; and (5) articles published in English and during or aft er 1998, the year of the publication of the fi rst cough clinical practice guideline. 13 
Study Identifi cation:
We conducted a systematic review of the literature using PubMed and Scopus on May 27, 2014, searching the literature from January 1, 1998, to May 27, 2014 . A total of 4,022 studies were initially identifi ed from the combined search (see Fig 2 19 for diagram of study selection). The Cochrane Database of Systematic Reviews was hand searched for the same time period to reassure that all relevant Studies with enough detail related to full cough guideline or protocol use to assess for intervention fi delity; exclude case series submitted as letters to the editor PICOTS 5 population, intervention, comparator, outcome, timing, setting.
reviews were included in the PubMed search. Th e search strategy was designed by experienced academic librarians (Nancy Harger, MLS, and Judy Nordberg, MLIS) working in collaboration with clinical experts (C. T. F. and R. S. I.). Th e search strategy for each database is described in e- Table 1 . Th e reference lists of narrative and systematic reviews were searched for relevant citations.
All titles and abstracts returned by the initial search were reviewed independently and in duplicate by two reviewers (C. T. F. and R. S. I.). A mediator was available to settle any potential disagreements. Potentially eligible studies underwent full text review following the same process.
Quality Assessment:
Final full text articles meeting the inclusion criteria were subjected to independent and duplicate quality assessment, based upon potential methodologic biases. Th e quality of studies was assessed with an adapted tool routinely used by CHEST to assess randomized controlled clinical trials in the development of their clinical practice guidelines. Th is tool, created by R. L. D. and associates, was developed for quality assessment of intervention studies, including randomized controlled trials and observational studies. 18 Data Extraction: Two reviewers worked independently and in duplicate to extract and enter data into a predesigned evidence table to ensure consistent and complete data extraction. Th e following data items were extracted: study design, primary aim, setting, population (eg, number of participants, age, sex, cough duration), number lost to follow-up or excluded, time to follow-up, number diagnosed with unexplained or unresolved cough, and description of patient outcome assessments. Additional data specifi c to the fi ve areas of intervention fi delity were collected in a separate data extraction table. A separate tool, developed as part of this work (e-Appendix 1), was used to rate intervention fi delity for each study. All studies were assessed for intervention fi delity using the tool, which included eight elements that addressed the fi ve areas of intervention fi delity. Th e following eight elements were sought in each study:
• Th ree elements for intervention fi delity strategies in study design : (1) Was the guideline or protocol used to guide the study published, and was it clearly identifi ed? (2) Did the authors identify the diagnostic methods for screening for causes of chronic cough according to the guideline or protocol cited or referenced (eg, cough duration and Each of the eight elements was rated for presence (yes or no) and for degree of presence using a rating scale ranging from 0, strongly disagree, to 6, strongly agree. Total intervention fi delity scores were computed as the sum of the eight item ratings that could range from 0 to 48, with Յ 23 5 poor, 24 to 35 5 fair, and 36 to 48 5 good.
Data Analysis: Th e fi nal studies that met the PICOTS criteria were carefully reviewed for homogeneity of study characteristics and key clinical information. They were analyzed in detail for the use of guidelines or protocols to manage chronic cough and the presence of our previously identifi ed intervention fi delity elements. Findings are described for the fi ve areas of interest according to our intervention fi delity tool. Because of the heterogeneity of study designs and quality, a meta-analysis could not be performed. Using the results of this systematic review as their basis, recommendations and suggestions were developed and submitted to the full panel for voting according to the CHEST Organization's methods previously published. 17 , 18 
Clinical Practice Guideline Recommendations and Suggestions
The methodology used by the CHEST Guideline Oversight Committee to select the Expert Cough Panel Chair and the international panel of experts to perform the systematic review, synthesize the evidence, and develop the recommendations and suggestions has been published. 17 , 18 Grading: In addition to the quality of the evidence, the recommendation grading also includes strength of recommendation dimension. In the context of practice recommendations, a strong recommendation applies to almost all patients, whereas a weak recommendation is conditional and only applies to some patients. In the context of research recommendations, such as the ones in this guideline, we intended a strong recommendation (Grade 1) to imply that we recommend using intervention fidelity strategies in all studies when patients with chronic cough are diagnosed and managed. Th e strength of a recommendation in this paper is based on consideration of three factors: balance of benefits to harms, patient values and preferences, and resource considerations. Harms incorporate risks and burdens to the patients, which can include convenience or lack of convenience, diffi culty of administration, and invasiveness. Th ese, in turn, impact patient preferences. Th e resource considerations go beyond economics and should also factor in time and other indirect costs. The authors 19 )
of these recommendations have considered these parameters in determining the strength of the recommendations and associated grades.
Th e fi ndings of the systematic review were used to support the evidencegraded recommendations or suggestions. A highly structured, consensusbased Delphi approach was used to provide expert advice on all guidance statements. The total number of eligible voters for each guidance statement varied based on the number of individuals recused from voting because of their potential conflicts of interest. Trans parency of process was documented. Further details of the methods related to conflicts of interest and transparency have been published elsewhere. 17 , 18 Results
Systematic review results are addressed first and categorized according to the study aims. Th is is followed by the results of the process for establishing guideline recommendations or consensus-based suggestions.
Systematic Review
Specifi c Aim 1: Develop and pilot a tool that assesses fi ve areas of intervention fi delity in the identifi ed studies and the degree to which they were used .
As the tool (e-Appendix 1) was trialed in the review, an iterative process was used and three adjustments to the tool were made. Adjustments included the following:
(1) For individual elements, additional detail was included for a better understanding, and wording was clarifi ed. It was also noted that although an item was oft en present, it may or may not have been well described or clearly implemented. (2) To address the variability in the degree that an item was described or implemented, the dichotomous rating scale (present or not) was supplemented with the 0-to 6-point rating scale (ie, 0 5 strongly disagree, to 6 5 strongly agree) described in detail under data extraction. Last, this aim was additionally modifi ed by using italic lettering as shown previously.
Specifi c Aim 2:
Systematically review the literature on studies that diagnosed and treated an initially unexplained chronic cough in adults, using a guideline or protocol, and determine whether the fi ve areas of intervention fi delity were addressed in the identifi ed studies and to what degree.
Characteristics of Included Studies:
Th e diagram 20 outlining the fl ow of study selection is shown in Figure 2 . 19 From our systematic review, 23 studies met our focused criteria. 4 , 21 -42 27 -33 When sex was reported, the percent of male subjects across the 23 studies ranged from 11.1% 22 to 60%. 37 No study reported race, and only one study reported ethnicity. 21 Cough duration was variably reported as mean or median with a wide range. Data related to time to patient follow-up were rarely reported. Unexplained cough, idiopathic cough, or cough unable to be resolved ranged from 0 21 , 37 to 42%. 4 Areas of Intervention Fidelity: Th e term intervention fi delity or a conceptually similar term was not identifi ed in any of the studies assessed. No study identifi ed a plan specifi cally addressing intervention fi delity to the study plan using the strategies as outlined by the Treatment Fidelity Workgroup of the NIH Behavioral Change Consortium as part of the study methods. Despite this fi nding, study design elements that were conceptually similar to those outlined by the Treatment Fidelity Workgroup were identifi ed, and, using our fi ve-area (eight-element) intervention fi delity tool, the studies were rated for the presence and degree to which they were used. A description of the elements of intervention fi delity present in the individual studies is provided in e- Table 2 . Table 3 provides a summary of the fi ndings from the 23 studies described in e- Table 2 . Table 4 provides average scores for overall and individual element degree of intervention fi delity identifi ed in the studies.
As shown in Table 4 , the overall degree of presence of the intervention fi delity elements was poor. Th e mean total score was poor for the prospective observational studies, fair for the randomized clinical trials, and poor for the retrospective study designs.
Intervention fi delity average summary ratings pertaining to elements of the three areas relating to the interventionists (items 1a, 1b, 1c, 2, 3a, 3b) ranged from 2.09 to 4.70 on a scale of 0 to 6 ( Table 4 ) . Th ese summary scores were higher than the average scores for the two areas relating to patients (items 4, 5) that included receipt of treatment (0.04) and enactment of treatment (0.48).
Study Design: Th is area consisted of three elements. First, "was the guideline or protocol used to guide the study published and was it clearly identifi ed?" Forty-seven percent (eight of 17) 22 -24 , 26 , 30 , 34 , 36 , 37 of the prospective observational studies, 50% (one of two) 41 of the randomized controlled studies, and 50% (two of four) 4 , 42 of the retrospective studies were primarily based upon a single guideline or protocol ( Table 3 ) . Forty-one percent (seven of 17) 21 , 28 , 31 , 35 , 38 -40 of the prospective observational studies, 50% (one of two) 29 of the randomized clinical trials, and 25% (one of four) 27 of the retrospective studies were underpinned by multiple guidelines or protocols. Th e guideline or protocol underpinnings were not clear for two 25 , 32 of the prospective observational studies and one of the retrospective observational studies. 33 Table 4 displays the degree of fi delity for this study design item for the described use of a published guideline or protocol. Because 52.2% (12 of 23) of all studies were primarily underpinned by the merging of more than one guideline or protocol or having it unclear as to what the basis for diagnosis and management was, it is not possible to determine if they were uniformly true to a published guideline or protocol. Average fi delity scores for this item by study design ranged from 3.75 to 5.06 ( Table 4 ).
Of the prospective observational studies, 22 , 28 , 30 -32 , 38 -40 47.1% (eight of 17) had extensive exclusion criteria, as did 100% of the randomized controlled trials. 29 , 41 These exclusionary criteria were not consistent from study to study. For example, some studies excluded smok ers 22 , 29 , 32 , 36 , 38 -40 or even former smokers of many years, 22 or were unclear on smoking as an exclusion, 23 , 24 whereas others did not exclude smokers. 4 , 21 , 25 , 27 , 28 , 30 , 31 , 33 -35 , 37 , 41 Second, "did the authors identify the diagnostic methods for screening for causes of chronic cough according to the guideline or protocol cited or referenced?" Th e average score for this item by study design ranged from 1.75 to 4.71 ( Table 4 ). Basing diagnostic testing on screening for gastroesophageal refl ux disease (GERD), only 47.0% (eight of 17) 24 , 26 , 30 -32 , 34 , 35 , 37 of the prospective observational studies, 0% (zero of two) 29 , 41 of the randomized controlled studies, and 0% (zero of four) 4 , 27 , 33 , 42 of the retrospective studies appeared to be consistent with the most recent guidelines cited in the article ( Table 3 , e- Table 3 ). Table 3 contains overall summary data, and e- Table 3 contains individual study data specifi c to the diagnosis and management of GERD. Diagnostic methods were evaluated based upon the most recent published guideline or protocol cited by the authors, and these varied by study. In summary, only 34.7% (eight of 23) appeared to use diagnostic criteria for GERD that were consistent with the most recent protocol or guideline referenced by the authors.
Th ird, "were standardized or validated tools used to measure patient reported outcomes?" Th e average score for this element by study design ranged from 1.00 to 5.00 ( Table 4 ) . Forty-seven percent (eight of 17) 21 , 28 , 30 -32 , 34 , 38 , 39 of the prospective observational studies, 100% (two of two) 29 , 41 of the randomized controlled studies, and 25% (one of four) 27 of the retrospective studies used a subjective previously validated or standardized subjective cough severity rating scale ( Table 3 ) . Although validated or standardized scales were used in these studies, in two of the prospective observational studies it was not clear how they were used in determining the diagnosis of cough. 32 , 34 Although multiple studies based response to treatment of cough as being no longer troublesome, none of the prospective observational studies and only 25% (one of four) 27 of the retrospective studies mentioned any type of cough-specifi c quality-of-life scale as an outcome vari able ( Table 3 ) . On the other hand, 100% (two of two) 29 , 41 ] (continued) (Continued) [ 1 The term unresolved cough encompasses a variety of diagnoses: idiopathic, not improved, unresponsive, chronic idiopathic cough, unresolved, "idiopathic or psychogenic", nonresponders, uncontrolled, unexplained, cause not determined. The term unresolved cough encompasses a variety of diagnoses, including idiopathic, not improved, unresponsive, chronic idiopathic cough, unresolved, "idiopathic or psychogenic," nonresponders, uncontrolled, unexplained, cause not determined.
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of the randomized controlled studies measured coughspecifi c quality of life using a validated questionnaire as an outcome measure.
Training of Providers:
Th is area consisted of one element with three parts: "was there formal training of providers related to the guideline or protocol used, and was an intervention manual used to guide providers?" Average scores for this item by study design ranged from 1.50 to 3.50 ( Table 4 ) . Only one prospective observational study 26 mentioned that multiple providers in all sites had received education and that quality control was used; yet, this study did not mention the use of a manual to guide intervention delivery ( Table 3 ) . One randomized controlled trial reported, in the methods section, that one arm of the trial was guided by an algorithm and with prescribed follow-up. 41 No other study mentioned any provider education or the use of an intervention manual to direct the use of the guideline or protocol. Th ere was no mention of whether there was deviation from the protocol or guideline on the part of the interventionist in any of the studies reviewed.
As summarized from appeared to have multiple physicians participating in patient management.
Delivery of Treatment:
Th is area included two elements. First, "were the core treatment interventions consistent with the guideline or protocol used to develop the intervention manual and/or to guide the study?" The average scores for this item by study design ranged from 1.75 to 3.00 ( Table 4 ) . As previously noted, a single multicenter study with multiple providers reported training and quality control but not the use of an intervention manual to guide the providers, and it was not clear if the training pertained to both diagnostic and management interventions. 26 No other study noted any education of providers or the use of a manual to direct care. Treatment descriptions varied in detail, content, and consistency with the primary guideline cited, with one study 23 providing a table that very clearly associated diagnoses with the history, examination, investigations, and treatment.
Looking specifi cally for treatment of GERD, at least one component of the most current recommendations referenced by the authors was not noted as being used for 58.8% (10 of 17) 21 , 23 , 28 , 30 -32 , 34 , 35 , 38 , 40 of the prospective observational studies ( Table 3 , e- Table 3 ). Management recommendations were evaluated based upon the most recent published guideline or protocol cited by the authors, and these varied by study. An additional 23.5% (four of 17) 22 , 25 , 36 , 39 of the prospective observational 1a 5 guideline/protocol; 1b 5 screening appropriate to 1a; 1c 5 validated/standardized cough outcome measure used; 2 5 providers with expanded knowledge of guidelines/protocols and education provided and manual used; 3a 5 core management interventions appropriate to 1a; 3b 5 response assessed; 4 5 reference to patient understanding as part of methods; 5 5 reference to patient's ability to use interventions in daily life. See Table 3 studies did not include enough information to assess for this item. Only 17.6% (three of 17) 24 , 26 , 37 of studies of this design appeared to consistently apply all treatments for GERD as recommended by the most recent guideline or protocols cited. Additionally, in 100% (two of two) 29 , 41 of the randomized controlled studies and 75% (three of four) 4 , 27 , 42 of retrospective studies, at least one component of GERD treatment specifi ed by the most current recommendations referenced by the authors was not noted. One retrospective study did not provide enough information to make a determination regarding GERD treatment. 33 Th ese fi ndings resulted in only 13.0% (three of 23) of the studies clearly being consistent to the most recent guideline or protocol regarding GERD treatment.
Th e second element of this area included: "was there assessment of response to treatment at specifi ed timeframes?" Average scores for this item by study design ranged from 2.00 to 6.00 ( Table 4 ) . Although most guidelines and protocols noted the need for reassessment and revision of the intervention plan, patient follow-up for reassessment posttreatment, when reported, varied greatly, with initial follow-up for those studies reporting data ranging from 5 days 27 to 3 months. 24 , 30 With respect to follow-up, although multiple studies included time for response to treatment as part of diagnostic criteria, many were not clear regarding time to initial follow-up and reassessment of response to treatment. Of the observational studies, 52.9% (nine of 17) 22 , 23 , 26 , 28 , 30 , 31 , 34 , 38 , 39 clearly included a time for initial follow-up as part of their methods, as did 50% (one of two) 29 of the randomized controlled trials and 25% (one of four) 27 of the retrospective observational studies ( Table 3 ). As noted under characteristics of studies, few provided data related to this element.
Receipt of Treatment:
Th is area included one element: "Was there any mention and/or measurement of concordance of patient and provider understanding of the problem and/or treatment recommendations?" Th e average scores for this item by study design ranged from 0.00 to 0.06 ( Table 4 ) . No study of any design specifi cally reported systematically assessing for or measuring patient understanding ( Table 3 ) . Although one study 21 mentioned the need for patient education, noting that . 30% of patients lacked an awareness of previous diagnoses, there was no mention of measuring patient understanding of the interventions used in any of the studies reviewed. One study noted that patients were instructed as to how to follow the treatment algorithm through to the next phone call but made no mention of addressing understanding. 28 An additional study promoted the need for protocol simplicity and sequential therapy to enhance patient adherence but did not address this issue in the methods. 39 One randomized controlled study mentioned that certifi ed respiratory educators followed an algorithm that included biweekly patient contact with explanation of diff erential diagnoses and the rationale for each intervention but made no mention of assessment of patient understanding. 41 Enactment of Treatment: Th is area included one element: "Was there any mention and/or measurement of patient's ability to engage in the treatment recommendations in daily life?" Th e average scores for this item by study design ranged from 0.00 to 1.00 ( Table 4 ) . No study of any design specifi cally reported systematically assessing for or measuring patient ability to engage in interventions in their daily life ( Table 3 ).
In evaluating the 23 studies for this area, reasons for not enacting treatment were classifi ed into those related to nonadherence and those related to side eff ects ( Table 3 ) . Although adherence and side eff ects are not synonymous with enactment, they give us insight into this area, as enactment was not measured in any study. Of the prospective observational studies, two provided data related to patient nonadherence but did not report whether adherence was systematically evaluated for within their methods. 21 , 32 Of these, one noted a 23% relapse rate due to nonadherence that was addressed during the study; however, reasons for nonadherence were not described. 21 Th e other study reported relapse of symptoms in six patients with postnasal drip syndrome and relapse in one patient secondary to stopping treatment of GERD. 32 Th e latter study also reported a patient who could not tolerate a proton pump inhibitor secondary to side eff ects and whose cough resolved with a change in therapy; although this study reported side eff ects, it was not clear if this was systematically addressed. 32 Additionally, two studies reported systematically assessing for side eff ects ( Table 3 ) . Although no association was made with adherence, one prospective observational study reported 10% of patients having side eff ects from treatment that included drowsiness and abdominal discomfort, with no patients dropping out secondary to this issue. 39 Of the randomized controlled trials, one reported assessing for and measuring side eff ects, noting the occurrence of 57 adverse events (eg, drowsiness, abdominal discomfort, dry mouth, dysuria, palpitations, or fatigue) with the use of their modifi ed protocol and 74 similar adverse events with their cited standard
protocol. 29 Two patients withdrew from this study because of side eff ects. 29 Th e four retrospective studies did not report data related specifi cally to patient adherence or side eff ects or generally related to the patient's ability to use recommended interventions in daily life. One retrospective study noted that at 1 year, 44% of those contacted by phone had a cough that persisted. 33 One study noted that smoking cessation was not addressed because patients were unlikely to quit because of cough. 28 Although no related data were supplied, two studies reported the potential impact of cost and access to care, respectively, 26 , 40 and one mentioned the impact of culture adversely aff ecting the application of care. 26 Only one study, a randomized controlled trial, mentioned teaching any physical skills (eg, inhaler use) in the deployment of recommended interventions. 41 Unresolved Cough as an Outcome: Unresolved cough encompasses terms such as idiopathic, not improved, unresponsive, chronic idiopathic cough, unresolved, "idiopathic or psychogenic, " nonresponders, uncontrolled, unexplained, and cause not determined, and averaged 10.5% with a range of 6.6% to 21.0% by study design (see Table 3 ). A fi nal diagnosis of unresolved cough ranged from 0% to 6.6% in the three single-provider studies. 21 , 23 , 37 For all studies, response to specifi c therapy was a criterion for establishing a diagnosis. It was not possible to determine whether unresolved cough in these studies referred to patients who were managed by guidelines or protocols and had no diagnosis or whether it included subjects who may have had an established diagnosis but did not respond to appropriate therapy.
Specifi c Aim 3:
Assess whether intervention fi delity was used to the extent that one can be confi dent that the diagnoses made were valid.
As revealed in Table 4 , intervention fi delity in the 23 studies selected for review was overall poor. Th e highest degree of intervention fi delity was in the two randomized controlled trials, yet they could only be rated as fair. Of the fi ve areas assessed, those related to receipt and enactment of treatment by the patients were barely addressed in the studies. Although the areas of study design, training of providers, and delivery of treatment were present to a modest degree, they were still inadequately addressed. Had we measured the methodologic intervention fi delity strategies, as specifi cally described by Treatment Fidelity Workgroup of the NIH Behavioral Change Consortium, rather than using conceptually similar elements, the fi ndings of this study related to intervention fi delity would have been worse.
Th ese fi ndings suggest that in studies of the diagnosis and treatment of patients with chronic cough that is initially of unknown cause before being worked up, intervention fi delity strategies were not systematically used as part of the methods. Addressing the fi ve areas of intervention fi delity has been proposed as being important to verifying treatment integrity, and treatment integrity is important to the validity of outcomes in intervention studies. In the area of study design, although most studies clearly cited one or more published guidelines or protocols as theoretically underpinning the study, they were not always clearly tied to the diagnostic or management interventions used. When assessing the methods used to determine whether chronic cough may be due to GERD, one or more of the criteria for establishing the diagnosis based upon the most recent guideline cited by the authors was oft en not present. Additionally, response to specifi c treatment was cited as at least part of the criteria for establishing a diagnosis, and, most oft en, this was not established using standardized or previously validated tools to ensure valid measurement of outcomes. Training of providers was rarely mentioned in the studies assessed, and the use of an intervention manual was never mentioned. In the area of delivery of treatment, when assessing the treatments delivered for GERD, they were most oft en missing at least one element of that proposed by what appeared to be the most recent of the guidelines or protocols cited by the authors, and they were therefore not true to the proposed theoretical underpinnings of the study. Receipt and enactment of treatment by the patient were also rarely addressed. Because treatment integrity was not verifi ed, we cannot be confi dent that the diagnoses established, based upon improvement in cough with specifi c treatment, were reliable and valid.
Summary of Evidence and Interpretation From the Systematic Review:
Th is review suggested that in studies of the diagnosis and treatment of patients with chronic cough that is initially of unknown cause before being evaluated, intervention fi delity strategies were not systematically used. Th erefore, one cannot be sure of the reliability and validity of study results. Our results lend credence to our hypothesis that routinely incorporating intervention fi delity as a methodologic strategy should improve the reliability and validity of the outcomes of studies using guidelines or protocols in the treatment of chronic cough in adults. Th e diagnostic and therapeutic interventions were used in diff erent ways, and it was not possible to be confi dent that core elements of guidelines were actually delivered and received as intended. Our results also support the supposition that the variability in success in treating chronic cough, as reported in the literature, may be due in part to guidelines or protocols not being implemented as planned by interventionists and patients.
Strengths and Limitations
Th e strengths of this systematic review include the novelty of addressing intervention fi delity in studies of the management of chronic cough and doing so using the most up to date and rigorous systematic review methodology. Strengths also include the development of a new tool to systematically assess for the presence of elements of and the degree of intervention fi delity in studies using guidelines for the diagnosis and management of chronic cough.
Th e limitations relate to the fact that the use of intervention fi delity strategies in studies using guidelines to diagnose and manage cough is an emerging area of study; therefore, tools and methods for extracting data are in their infancy. Th e data extracted are also limited based upon their subjective nature and what was documented.
Other limitations relate to the lack of direct mention of intervention fi delity strategies in the methods of the studies reviewed. Th erefore, we had to assess for elements that were conceptually similar. In addition, there was a lack of comparative studies, very few randomized controlled clinical trials, the likelihood of publication bias, absence of validated tools to assess cough outcomes, heterogeneity regarding the populations studied based upon variable defi nitions of chronic cough, and the small number of patients enrolled in the studies. Although the locations where the studies were carried out were culturally diverse, we took this into account by only holding the authors accountable for what they said they did.
Our inability to pool data due to the heterogeneity of the studies for meta-analysis was also a limitation. Because of these limitations, it was not possible to correlate the degree of intervention fi delity with the number of patients with unresolved chronic cough. For example, although Table 3 reveals that there were fewer patients diagnosed with unresolved chronic cough in the prospective observational studies (6.55%) compared with those in the randomized controlled clinical trials (20.55%), this does not seem intuitively plausible and may be an artifact due to the bias associated with the less frequent use of reliable and validated patient outcome measures in the observational studies. It is also possible that randomized controlled trials do not allow for adequate fl exibility and individualization associated with guideline implementation and, therefore, do not provide the best assessment of real-life settings, further supporting the need for the use of intervention fi delity strategies.
Recommendations and Suggestions
Based upon the systematic review, the Expert Cough Panel was able to make a series of recommendations and/or suggestions for the use of intervention fi delity, by those conducting research, in studies of adults with chronic cough who are being diagnosed and managed using an evidence-based clinical practice guideline or protocol. Th e recommendations or suggestions are presented in stepwise fashion to provide a systematic plan in logical sequential order so that all fi ve areas of intervention fi delity are addressed from creation of the study design through activation of the intervention fi delity strategies.
2.
3. In conducting studies of chronic cough in adults, we recommend that investigators, as a third step, establish a standardized plan for delivery and measurement of treatment through the use of an intervention manual (Grade 1C) .
4.
In conducting studies of chronic cough in adults, we recommend that investigators, as a fourth step, establish a standardized plan for maximizing and measuring concordance of understanding of interventions and treatment between subjects and investigators (Grade 1C) .
5.
In conducting studies of chronic cough in adults, as a fi ft h step, we recommend that investigators establish a standardized plan for evaluating and measuring the subject's ability to enact and adhere to the treatment plan under real life circumstances (Grade 1C) .
6. In conducting studies of chronic cough in adults, we recommend that investigators not make a diagnosis of idiopathic chronic cough as a distinct clinical entity unless known causes of cough have been excluded by a systematic evaluation using an evidence-based guideline and intervention fi delity has been addressed in the design and implementation of the study (Grade 1C) .
Areas for Future Research and Clinical Practice
To advance the fi eld and provide trustworthy guidelines to guide clinical practice, there are a number of potential future research issues that should be addressed. They are enumerated below:
• To improve the internal and external validity of future studies seeking to diagnose and manage chronic cough in adults, researchers should use the recommendations and suggestions related to intervention fi delity made in this document. If researchers are not able to use these recommendations, they should document why there were not able to do so. • To carry out the future studies, tools need to be developed to guide and monitor the intervention fi delity strategies provided in our recommendations and suggestions such as an intervention manual (see example in e-Appendix 2) and a tool to measure interventionist-patient concordance of understanding of management (see example in e-Appendix 2). Th e feasibility of using the tools in e-Appendix 2 has previously been reported. 43 In addition to suggesting appropriate tools, the intervention manual in e-Appendix 2 also provides suggested steps for researchers to follow to carry out clinical studies that satisfy the fi ve areas of intervention fi delity.
• Benefi ts and harms associated with patient care should be considered in future studies using intervention fi delity strategies. At this time, benefi ts are believed to greatly outweigh harms, because not following current guidelines may result in patients not getting maximal benefi t out of being evaluated for chronic cough. Additionally, there may be a potential for diagnostic mislabeling, and patients may be exposed to unnecessary harm associated with interventions that may not have been indicated. Guidelines are meant to guide patient care, and as such, they do not preclude the need to adjust care to the individual patient situation. By measuring receipt and enactment of treatment, in particular, we are likely to develop greater insight into the benefi ts and harms associated with the use of these guidelines.
Conclusions
Since publication of the 2006 Chest Cough Guidelines, and based upon this systematic review, it is clear that some of the variability in the reporting of successful management patients with chronic cough may be due to lack of intervention fi delity. Using these results, the Expert Cough Panel has been able to make a series of recommendations and suggestions directed at researchers for carrying out future studies of chronic cough in adults. By following the recommendations and suggestions in this article, patients will likely benefi t, as their providers will be managing them according to more reliable and valid studies. Improved research will strengthen the evidence used in clinical practice guidelines that clinicians use when counseling patients regarding benefi ts and harms associated in their management.
